Impact of Brokerage Rating on PAREXEL International Corporation(PRXL)

Many PAREXEL International Corporation(PRXL) Stock Research Financial Advisors from Investment Banking firms have advised their client and investors on the stock. PAREXEL International Corporation was Downgraded by Credit Suisse to Neutral on Feb 6, 2017. PAREXEL International Corporation was Downgraded by Citigroup to Neutral on Feb 3, 2017. PAREXEL International Corporation was Downgraded by Deutsche Bank on Feb 3, 2017 to Sell, Price Target of the shares are set at $53.PAREXEL International Corporation was Downgraded by Raymond James to Underperform on Feb 2, 2017. PAREXEL International Corporation was Downgraded by Goldman to Sell on Dec 16, 2016.

Company has reported several Insider transactions to the SEC, on Feb 10, 2017, Gadi Saarony (Senior Vice President, CRS) sold 2,325 shares at 64.54 per share price.On Aug 10, 2016, Joshua Schultz (SVP, PAREXEL Access) sold 2,500 shares at 68.64 per share price.On Jun 14, 2016, A Dana Jr Callow (director) sold 3,000 shares at 60.04 per share price.

PAREXEL International Corporation Last issued its quarterly earnings results on Oct 26, 2016. The company reported $0.76 EPS for the quarter, missing the analyst consensus estimate by $ -0.10. Analyst had a consensus of $0.86. The company had revenue of $500.90 million for the quarter, compared to analysts expectations of $524.75 million. The companys revenue was down -2.2 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $0.70 EPS.

PAREXEL International Corporation (NASDAQ:PRXL) has received a short term rating of strong sell from experts at Zacks with a rank of 5. The stock has been rated an average of 3.29 by 14 Brokerage Firm. 1 Wall Street Firms have rated the stock as a strong buys. 10 Brokerage Firms have advised hold. 3 Analysts have rated it as strong sell.

PAREXEL International Corporation (NASDAQ:PRXL): 10 Analyst have given the stock of PAREXEL International Corporation (NASDAQ:PRXL) a near short term price target of $64.45. The standard deviation reading, which is a measure by which the stock price is expected to swing away from the mean estimate, is at $8.83. The higher price target estimate is at $76 while the lower price estimates are fixed at $49.

PAREXEL International Corporation (NASDAQ:PRXL) rose 2.42% or 1.56 points on Tuesday and made its way into the gainers of the day. After trading began at $64.11 the stock was seen hitting $66.02 as a peak level and $64.11 as the lowest level. The stock ended up at $65.91. The daily volume was measured at 1,070,467 shares. The 52-week high of the share price is $72.32 and the 52-week low is $51.16. The company has a market cap of $3,358 million.

Parexel International Corporation is one of the largest biopharmaceutical outsourcing organizations in the world, providing a broad range of knowledge-based contract research, medical marketing and consulting services to the worldwide pharmaceutical, biotechnology and medical device industries. With a commitment to providing solutions that expedite time-to-market and peak market penetration, PAREXEL has developed significant expertise in clinical trials management, data management, biostatistical analysis, medical marketing, clinical pharmacology, regulatory and medical consulting, industry training and publishing and other drug development consulting services. Its information technology subsidiary, Perceptive Informatics, Inc., develops and offers a portfolio of innovative technology-based products and services that facilitate clinical drug development and are designed to decrease time to peak sales.

PAREXEL

Share this post

Leave a Reply